TIMP2 and breast cancer: Additionally, carriers of the TIMP-2 rs8179090 CG + CC genotypes exhibited a significantly higher risk for BC than GG carriers in the dominant model (OR = 1.30, 95%CI = 1.09–1.55, p = 0.0034).